Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Delia Johnson

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Preventive Cardiology|July 10, 2007
Associations among walking performance, physical activity, and subclinical cardiovascular diseaseKelley K Pettee, Beth M Larouere, Andrea M Kriska, et al.
Circulation|February 19, 2004
Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome EvaluationOscar C Marroquin, Kevin E Kip, David E Kelley, et al.
Plos One|May 8, 2014
TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)John W Petersen, B Delia Johnson, Kevin E Kip, et al.
American Journal of Hypertension|September 20, 2008
Pulse pressure and adverse outcomes in women: a report from the Women's Ischemia Syndrome Evaluation (WISE)R David Anderson, B Clay Sizemore, Genevieve M Barrow, et al.
European Heart Journal|May 25, 2006
Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) studyB Delia Johnson, Leslee J Shaw, Carl J Pepine, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2006
Phytoestrogens and lipoproteins in womenC Noel Bairey Merz, B Delia Johnson, Glenn D Braunstein, et al.
The American Journal of Medicine|January 23, 2017
Migraine Headache and Long-Term Cardiovascular Outcomes: An Extended Follow-Up of the Women's Ischemia Syndrome EvaluationCecil A Rambarat, Islam Y Elgendy, B Delia Johnson, et al.
Journal of Women'S Health (2002)|September 27, 2006
Obesity distribution and reproductive hormone levels in women: a report from the NHLBI-sponsored WISE StudyMarian B Olson, Leslee J Shaw, Eloise E Kaizar, et al.
Women'S Health (London, England)|September 7, 2013
Clinical implications of the Women's Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomesEileen M Handberg, Jo-Ann Eastwood, Wafia Eteiba, et al.
American Heart Journal|November 18, 2005
Global inflammation predicts cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) studyKevin E Kip, Oscar C Marroquin, Leslee J Shaw, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Preventive Cardiology|July 10, 2007
Associations among walking performance, physical activity, and subclinical cardiovascular diseaseKelley K Pettee, Beth M Larouere, Andrea M Kriska, et al.
Circulation|February 19, 2004
Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome EvaluationOscar C Marroquin, Kevin E Kip, David E Kelley, et al.
Plos One|May 8, 2014
TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)John W Petersen, B Delia Johnson, Kevin E Kip, et al.
American Journal of Hypertension|September 20, 2008
Pulse pressure and adverse outcomes in women: a report from the Women's Ischemia Syndrome Evaluation (WISE)R David Anderson, B Clay Sizemore, Genevieve M Barrow, et al.
European Heart Journal|May 25, 2006
Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) studyB Delia Johnson, Leslee J Shaw, Carl J Pepine, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2006
Phytoestrogens and lipoproteins in womenC Noel Bairey Merz, B Delia Johnson, Glenn D Braunstein, et al.
The American Journal of Medicine|January 23, 2017
Migraine Headache and Long-Term Cardiovascular Outcomes: An Extended Follow-Up of the Women's Ischemia Syndrome EvaluationCecil A Rambarat, Islam Y Elgendy, B Delia Johnson, et al.
Journal of Women'S Health (2002)|September 27, 2006
Obesity distribution and reproductive hormone levels in women: a report from the NHLBI-sponsored WISE StudyMarian B Olson, Leslee J Shaw, Eloise E Kaizar, et al.
Women'S Health (London, England)|September 7, 2013
Clinical implications of the Women's Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomesEileen M Handberg, Jo-Ann Eastwood, Wafia Eteiba, et al.
American Heart Journal|November 18, 2005
Global inflammation predicts cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) studyKevin E Kip, Oscar C Marroquin, Leslee J Shaw, et al.
Pageof 9